PATENT CLAIM ANALYSIS

Application Number: 15953494
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "235800"]

Abstract:
Disclosed are novel compounds of Formula I that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

Claim (Index 18):
The compound of  claim 14 , or a pharmaceutically acceptable salt thereof, wherein R 2a  is hydrogen, Cl, Br, or methyl.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 91.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15953492', '12096432', '14343410', '12312749', '15522969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7654752883775449
- 35 USC 102 Novelty (BERT): 0.56078602088565
- Combined Prediction Score: 0.7450063616283553
- Mean Citation Score: 329.689702
- Max Citation Score: 430.0401
- Similarity Product: 320.16430817255974

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test